By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


Company News
Probiodrug AG Announces Results Of Chronic Toxicology Studies With PQ912, Its "First In Class" Glutaminyl Cyclase (QC) Inhibitor For The Treatment Of Alzheimer’s Disease 4/4/2016 9:21:02 AM
Probiodrug AG Appoints Mark Booth As Chief Business Officer 3/23/2016 8:56:33 AM
Probiodrug AG Reports Full Year 2015 Financial Results 3/15/2016 9:38:39 AM
Probiodrug AG’s pGlu-Abeta Approaches Being Presented At 14th AAT Symposium On Advances In Alzheimer Therapy 3/9/2016 8:57:36 AM
Probiodrug AG To Publish Its Full Year 2015 Results On March 15, 2016 3/7/2016 9:39:10 AM
Key Patents Granted For Probiodrug AG’s pGlu-Abeta Targeting Monoclonal Antibody Program For The Treatment Of Alzheimer’s Disease 1/11/2016 9:55:19 AM
Probiodrug AG Announces Publication Of Initial PQ912 Clinical Data Demonstrating Inhibition Of Glutaminyl Cyclase 12/15/2015 10:47:25 AM
Probiodrug AG Reports Third Quarter 2015 Business Update 11/19/2015 10:32:09 AM
Probiodrug AG Completes Capital Increase 11/6/2015 9:02:50 AM
Probiodrug AG Presented Data On Its pglu-3 Abeta Monoclonal Antibody At Neuroscience 2015, Chicago 10/19/2015 11:21:12 AM